Cargando…
Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial
BACKGROUND: The aim of this study was to compare the antihypertensive efficacy of losartan 100 mg + hydrochlorothiazide (HCTZ) 25 mg versus bisoprolol 10 mg + HCTZ 25 mg and their influence on arterial stiffness and central blood pressure (BP). METHODS: Of 60 patients with a mean BP of 173.3 ± 1.7/9...
Autores principales: | Radchenko, GD, Sirenko, YM, Kushnir, SM, Torbas, OO, Dobrokhod, AS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792946/ https://www.ncbi.nlm.nih.gov/pubmed/24109189 http://dx.doi.org/10.2147/VHRM.S44568 |
Ejemplares similares
-
Randomized study to compare valsartan ± HCTZ versus amlodipine ± HCTZ strategies to maximize blood pressure control
por: Zappe, Dion, et al.
Publicado: (2009) -
Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ
por: Duprez, Daniel, et al.
Publicado: (2011) -
Predictors of high central blood pressure in young with isolated systolic hypertension
por: Radchenko, GD, et al.
Publicado: (2016) -
Efficacy of ARB/HCTZ Combination Therapy in Uncontrolled Hypertensive Patients Compared with ARB Monotherapy: A Meta-Analysis
por: Ma, Linlin, et al.
Publicado: (2021) -
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans
por: Del-Aguila, J L, et al.
Publicado: (2014)